Skip to main content
. 2020 Jun 30;478(12):2786–2797. doi: 10.1097/CORR.0000000000001392

Table 2.

Staphylococcus species recovered from preoperative synovial fluid and intraoperative tissue samples

Staphylococcus species Number (%) of positive culture results Number (%) of false-positive SF culture resultsc Number (%) of false-negative SF culture resultsd
Preoperative SF samplesa Intraoperative tissue samplesb
S. aureus 31% (25 of 80)e 35% (25 of 71)f 12% (3 of 25) 12% (3 of 25)
S. epidermidis 44% (35 of 80) 42% (30 of 71) 26% (9 of 35) 13% (4 of 30)
S. lugdunensis 10% (8 of 80) 11% (8 of 71) 0% 0%
Other species 15% (12 of 80) 11% (8 of 71) 50% (6 of 12) 25% (2 of 8)
S. capitis 10% (8 of 80) 7% (5 of 71) 38% (3 of 8) 0%
S. caprae 1% (1 of 80) 1% (1 of 71) 0% 0%
S. haemolyticus 1% (1 of 80) 0% 50% (1 of 2) NA
S. hominis 1% (1 of 80) 1% (1 of 71) 100% (1 of 1) 100% (1 of 1)
S. saccharolyticus 1% (1 of 80) 0% 100% (1 of 1) NA
S. xylosus 0% 1% NA 100% (1 of 1)
a

At least one synovial fluid sample has positive culturing results.

b

At least one tissue sample had culturing results positive for S. aureus and at least two tissue sample results positive for CNS.

c

Staphylococcus species isolated from synovial fluid and not cultured as a significant organism (as defined in footnote b) from an intraoperative tissue sample.

d

Staphylococcus species recovered as a significant organism (as defined in footnote b) from an intraoperative tissue sample and not cultured from synovial fluid.

e

Number/total number of staphylococcal species cultured from synovial fluid.

f

Number/total number of staphylococcal species cultured from intraoperative samples; SF = synovial fluid.